. 2003 Apr 25;138(8):1485–1494. doi: 10.1038/sj.bjp.0705212

Table 4.

mRNA expression in the non−infarcted left ventricle (NILV), and right ventricle (RV) of the 2 week post−MI rat, and the effect of irbesartan (IRB)

	NILV		RV
	MI (n=4)	MI+IRB (n=4–7)	MI (n=4–5)	MI + IRB (n=5–9)
prepro−ANP	12±5^*	25±3^**	9±2^*	2±1^***
mRNA
prepro−BNP	10±2^*	17±4^**	6±2^*	1±1^***
mRNA
Fibronectin	5±1^*	8±2^**	4±1^*	4±1^**
mRNA

mRNA data in the myocardial infarct (MI) group is presented as fold increase±s.e.m. versus sham rat. MI+IRB mRNA data is presented as fold increase±s.e.m. versus IRB−treated sham rats.

Represents P<0.05 versus sham rat;

^**

Represents P<0.05 versus IRB−treated sham rat;

^***

Represents P<0.05 versus untreated MI rat; mRNA expression was normalized to GAPDH mRNA; and (n) denotes number of rats examined.